LEO 43204 gel

DRUG3 trials

Sponsors

LEO Pharma

Conditions

Actinic Keratosis

Phase 3

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

CompletedNCT02547363

LEO PharmaActinic Keratosis

Start: 2015-11-30End: 2017-08-31Updated: 2025-03-10

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

CompletedNCT02547233

LEO PharmaActinic Keratosis

Start: 2015-11-30End: 2017-11-30Updated: 2025-03-10

Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up

CompletedNCT02549339

LEO PharmaActinic Keratosis

Start: 2015-11-13End: 2017-08-10Updated: 2025-03-10